Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Fang Fang, Pei Zhuang, Xue Feng, et al.
Molecular Therapy (2022) Vol. 30, Iss. 4, pp. 1421-1431
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering
James R. Tribble, Flora Hui, Heberto Quintero, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101193-101193
Open Access | Times Cited: 55
NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport
Sen Yang, Zhen-Xian Niou, Andrea Enriquez, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
Pingting Liu, Wei Chen, Haowen Jiang, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 13-27
Open Access | Times Cited: 18
The concept of gene therapy for glaucoma
Robert Sulak, Xiaonan Liu, Adrian Smędowski
Neural Regeneration Research (2023) Vol. 19, Iss. 1, pp. 92-99
Open Access | Times Cited: 17
Highly Bioadaptable Hybrid Conduits with Spatially Bidirectional Structure for Precision Nerve Fiber Regeneration via Gene Therapy
Renliang Zhao, Xiangtian Deng, Jizhao Dong, et al.
Advanced Science (2024) Vol. 11, Iss. 19
Open Access | Times Cited: 5
Inhibiting the SARM1-NAD+ axis reduces oxidative stress-induced damage to retinal and nerve cells
Yannan Zhang, Yihua Yao, Juhua Yang, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112193-112193
Open Access | Times Cited: 5
Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance
Che‐Yuan Kuo, Catherine Jui-Ling Liu
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1884-1884
Open Access | Times Cited: 19
Lhx2 promotes axon regeneration of adult retinal ganglion cells and rescues neurodegeneration in mouse models of glaucoma
Changping Li, Shen Wu, Sun Yong-quan, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101554-101554
Open Access | Times Cited: 4
NMNAT2 is a druggable target to drive neuronal NAD production
James R. Tribble, Melissa Jöe, Carmine Varricchio, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Self‐Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Xuezhi Zhou, Rong Rong, Ganghao Liang, et al.
Advanced Science (2024) Vol. 11, Iss. 41
Open Access | Times Cited: 4
Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies
L. H. Wang, Chun-Hao Huang, I‐Chan Lin
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1261-1261
Open Access | Times Cited: 4
Electroceuticals and optogenetics for neuroprotection, vision preservation and restoration
Najam A. Sharif, Samarendra Mohanty
Elsevier eBooks (2025), pp. 163-178
Closed Access
Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration
Dong Liu, Hannah C. Webber, Fuyun Bian, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight
Solange Sarkis, Chloé Chamard, Bianca Johansen, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases
Feifei Li, Chou Wu, Gelin Wang
Neuroscience Bulletin (2023) Vol. 40, Iss. 2, pp. 218-240
Open Access | Times Cited: 9
The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Kathy Ming Feng, Ta-Hsin Tsung, Yi‐Hao Chen, et al.
Cells (2023) Vol. 12, Iss. 24, pp. 2797-2797
Open Access | Times Cited: 7
NMNAT2: An important metabolic enzyme affecting the disease progression
Wentao Li, Mengxiang Gao, Chunhui Hu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114143-114143
Open Access | Times Cited: 12
Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucoma
Huilan Zeng, Jordan E. Mayberry, David Wadkins, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Programmed axon death: a promising target for treating retinal and optic nerve disorders
Andrea Loreto, Elisa Merlini, Michael P. Coleman
Eye (2024) Vol. 38, Iss. 10, pp. 1802-1809
Open Access | Times Cited: 2
The ZDHHC13/ZDHHC17 subfamily: from biological functions to therapeutic targets of diseases
Ying Zhang, Sisi Fan, Lu He, et al.
Pharmacological Research (2024), pp. 107418-107418
Open Access | Times Cited: 2
Gene therapy for glaucoma: Targeting key mechanisms
Jeff Henderson, Jeffrey O’Callaghan, Matthew Campbell
Vision Research (2024) Vol. 225, pp. 108502-108502
Open Access | Times Cited: 2
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Jing Liao, Zhaoguang Lai, Guangyi Huang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116042-116042
Open Access | Times Cited: 6
Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration
Bogdan Beirowski
Neurobiology of Disease (2022) Vol. 170, pp. 105751-105751
Closed Access | Times Cited: 9
Therapeutic strategies for glaucoma and optic neuropathies
Jung Lo, Kamakshi Mehta, Armaan Dhillon, et al.
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101219-101219
Open Access | Times Cited: 5
Inducible Rbpms-CreERT2 Mouse Line for Studying Gene Function in Retinal Ganglion Cell Physiology and Disease
Luming Guo, Xiaoling Xie, Jing Wang, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1951-1951
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top